Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia

References

• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000;32(Suppl 1):157–70.
   PubMedGoogle Scholar
• Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38(Suppl):69–89.
   Google Scholar
• Gines P, Fernandez-Esparrach G, Arroyo V, Rodes J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997;17:175–89.
   PubMed Web of Science ®Google Scholar
• Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46–52.
   PubMed Web of Science ®Google Scholar
• Castellano G, Solis-Herruzo JA, Morillas JD, Larrodera L, Coca C, Gamarra-Gonzalez A, Antidiuretic hormone and renal function after water loading in patients with cirrhosis of the liver. Scand J Gastroenterol 1991;26:49–57.
   PubMed Web of Science ®Google Scholar
• Gatta A, Caregaro L, Angeli P, Merkel C, Menon F, Rondana M, Impaired renal water excretion in liver cirrhosis. The role of reduced distal delivery of sodium. Scand J Gastroenterol 1988;23:523–8.
   PubMed Web of Science ®Google Scholar
• Hendrickse MT, Triger DR. Vagal dysfunction and impaired urinary sodium and water excretion in cirrhosis. Am J Gastroenterol 1994;89:750–7.
   PubMed Web of Science ®Google Scholar
• Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229–36.
   PubMed Web of Science ®Google Scholar
• Cosby RL, Yee B, Schrier RW. New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab 1989;15:261–6.
   PubMedGoogle Scholar
• Moreau R, Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 2006;43:385–94.
   PubMed Web of Science ®Google Scholar
• Kalambokis GN, Tsianos EV. Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. Hepatology 2008;48:686.
   PubMedGoogle Scholar
• Krag A, Moller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 2007;46:1863–71.
   PubMed Web of Science ®Google Scholar
• Kalambokis G, Fotopoulos A, Economou M, Pappas K, Tsianos EV. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol 2007;46:213–21.
   PubMedGoogle Scholar
• Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 1998;28:937–43.
   PubMedGoogle Scholar
• Hirasawa A, Shibata K, Kotosai K, Tsujimoto G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem Biophys Res Commun 1994;203:72–9.
   PubMedGoogle Scholar
• Pugh R, Murry-Lyon I, Dawson J, Pietroni M, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258–66.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007;56:1310–8.
   PubMed Web of Science ®Google Scholar
• Escorsell A, Bandi JC, Moitinho E, Feu F, Garcia-Pagan JC, Bosch J, Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997;26:621–7.
   PubMed Web of Science ®Google Scholar
• Epstein M. Derangement of renal water handling in liver disease. Gastroenterology 1985;89:1415–25.
   PubMed Web of Science ®Google Scholar
• Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982;307:1552–7.
   PubMed Web of Science ®Google Scholar
• Bichet DG, Szatalowicz V, Chaimovitz C, Schrier RW. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med 1982;96:413–7.
   PubMed Web of Science ®Google Scholar
• Castellano G, Solis-Heruzo JA, Gonzalez A, Morillas JD, Moreno D, Munoz T, Plasma arginine vasopressin response to oral, gastric, and intravenous water load in patients with cirrhosis. Gastroenterology 1994;106:678–85.
   PubMedGoogle Scholar
• Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995;109:1917–25.
   PubMed Web of Science ®Google Scholar
• Kalambokis G, Economou M, Kosta P, Papadimitriou K, Pappas C, Katsaraki A, Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. J Gastroenterol Hepatol 2005;20:1075–81.
   PubMed Web of Science ®Google Scholar
• Narahara Y, Kazanawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 2009;24:1791–7.
   PubMed Web of Science ®Google Scholar
• Krag A, Bendtsen F, Pedersen EB, Holstein-Rathlou NH, Moller S. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. Am J Physiol Renal Physiol 2008;295:FI295–300.
   Google Scholar
• Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology 2006;105:599–612.
   PubMed Web of Science ®Google Scholar
• Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De las HD, Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002;36:941–8.
   PubMed Web of Science ®Google Scholar